Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 26, 2020, Sandesh Mahatme informed Sarepta Therapeutics, Inc. (the "Company") of his resignation from his positions as the Company's Executive Vice President, Chief Financial Officer and Chief Business Officer, effective as of July 10, 2020. Mr. Mahatme's decision to resign did not result from any disagreement with the Company on any matter relating to the Company's operations, financial statements, internal controls, policies or procedures. The Company thanks Mr. Mahatme for his substantial contributions during a transformational period for the Company and wishes him well in his future endeavors.





                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses